APA (7th ed.) Citation

L, P., GW, S., P, F., U, S., J, M., J, S., . . . S, v. V. (2026). Pyelonephritis decreases serum cholesterol and mitigates atherosclerosis severity despite systemic inflammation. American journal of physiology. Heart and circulatory physiology, 330(4), H1012. https://doi.org/10.1152/ajpheart.00914.2025

Chicago Style (17th ed.) Citation

L, Possenriede, Sendtner GW, Falahat P, Scheidt U, Miranda J, Schmitz J, Bräsen JH, and von Vietinghoff S. "Pyelonephritis Decreases Serum Cholesterol and Mitigates Atherosclerosis Severity Despite Systemic Inflammation." American Journal of Physiology. Heart and Circulatory Physiology 330, no. 4 (2026): H1012. https://doi.org/10.1152/ajpheart.00914.2025.

MLA (9th ed.) Citation

L, Possenriede, et al. "Pyelonephritis Decreases Serum Cholesterol and Mitigates Atherosclerosis Severity Despite Systemic Inflammation." American Journal of Physiology. Heart and Circulatory Physiology, vol. 330, no. 4, 2026, p. H1012, https://doi.org/10.1152/ajpheart.00914.2025.